Key result
Recent developments in antiarrhythmic drugs focus on atrium-selective agents and amiodarone-like multichannel blockers, driven by a better understanding of cardiac ionic channels.
Design
Review
Authors
Loading...
No immediate practice change; leaves open whether atrium-selective agents improve AF outcomes.
This expert review highlights the ongoing development of atrium-selective and multichannel-acting antiarrhythmic drugs targeting specific cardiac ionic channels.
Keitaro Hashimoto (2011) conducted a review in Arrhythmias. Antiarrhythmic drugs was evaluated. Recent developments in antiarrhythmic drugs focus on atrium-selective agents and amiodarone-like multichannel blockers, driven by a better understanding of cardiac ionic channels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: